BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Other News

Cetero Research supply/service news

FDA is notifying pharmaceutical companies that bioanalytical studies conducted at a Houston lab owned by CRO Cetero Research may need to be repeated after agency inspections found significant instances of misconduct, including...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >